“crohns disease”的搜索结果，显示 151-160 项，共有 8231 项

1. 耳鼻喉科(ENT) /头颈外科- 临床试验- 妙佑医疗国际

   The purpose of this study is to identify a biomarker (or biomarkers) that is present when disease is present (i.e., at diagnosis or recurrence) and not ...

2. 多囊性肾病- 症状与病因- 妙佑医疗国际

   如果父母双方均携有这种疾病的基因，则其孩子患该病的概率为25%。 风险因素. The biggest risk factor for getting polycystic kidney disease is getting the gene ...

3. 神经科- 临床试验- 妙佑医疗国际

   The goals of the study are to prospectively evaluate clinical and laboratory biomarkers of multiple system atrophy and Parkinson's disease at early clinical ...

4. 胃肠病科和肝病科- 临床试验- 妙佑医疗国际

   Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in the world and a major public health issue in the US. It is ...

5. 肾上腺癌- 医生与科室- 妙佑医疗国际

   ... disease, Adrenal cancer, Thyroid cancer, Hypoth... ... disease, Parathyroid cancer. 显示更多擅长领域 ... Crohn's disease, Familial adenomatous polyposis ...

6. 神经科- 临床试验- 妙佑医疗国际

   ... disease stage. Analyses of Metabolic Agents Following Brain Radiation. Rochester, Minn. The purpose of this study is to determine the feasibility of serial ...

7. 神经科- 临床试验- 妙佑医疗国际

   The purpose of this study is to identify clinical characteristics and biomarkers predictive of disease outcome, progression, and treatment response in ...

8. 胃肠病科和肝病科- 临床试验- 妙佑医疗国际

   Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in the world and a major public health issue in the US. It is ...

9. 肾移植项目- Kidney transplant for polycystic kidney disease - 妙佑医疗国际

   Kidney transplant for polycystic kidney disease · 评估减慢多囊性肾病进展的治疗方法的临床试验 · 筛查脑动脉瘤 · 治疗多囊性肝病 · 家人的基因检测和咨询以及家人的治疗 ...

10. 妙佑医疗国际 - 排便频繁 定义

    gov/health-information/digestive-diseases/celiac-disease. Accessed Oct. 22, 2020. What is inflammatory bowel disease (IBD)? Centers for Disease Control and ...